The Immunomodulatory Effects of Oral Nanocurcumin in Multiple Sclerosis Patients
Clinical trial NCT03150966 · COMPLETED
Trial details
- NCT number
- NCT03150966
- Sponsor
- Tabriz University of Medical Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-08
- Primary completion
- 2017-08-10
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.